Brief: Onesource Specialty Pharma March-Quarter Consol Profit 46 Million Rupees
13/05/2026 08:36
May 13 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS: MARCH-QUARTER CONSOL PROFIT 46 MILLION RUPEES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.3 BILLION RUPEES Source text: [ID:] Further company coverage: ONEO.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onesource Specialty Pharma
See all newsBrief: Onesource Specialty Pharma Not To Pursue Merger Of Facilities Of Steriscienceat With Co
Brief: Onesource Specialty Pharma March-Quarter Consol Profit 46 Million Rupees
Brief: Onesource Specialty Pharma Says Orbicular Secures Tentative U.S. FDA ANDA Approval For Generic Ozempic
Brief: Onesource Specialty Pharma Says EU-GMP Certification For Unit II Manufacturing Facility Renewed
Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia